MedTrace Logo

A Dyadic Approach for Promoting Physical Activity Among People with MS and Their Support Partners

NCT04267185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-12-12

No results posted yet for this study

Summary

Both people with multiple sclerosis (MS) and their family caregivers experience the impact of this neurodegenerative disease on their health and well-being. The person living with MS and their support partner need to work together as a team to find ways to manage the disease. A physical activity (PA) program that uses a 'dyadic approach' is one possible way of managing the impact of MS. Dyadic programs are unique because they target both people with the disease and their caregivers together to increase their PA levels. This pilot study will deliver a 12-week program using group teleconference and one-on-one support phone calls to teach participants simple methods to change PA patterns in daily life. For example, they will learn how to set personal goals to increase PA and reduce sitting time.

Conditions

Interventions

BEHAVIORAL

Physical Activity Together for PwMS and their CGs (PAT-MS)

A dyadic physical activity intervention approach for PwMS and their family CGs affected by moderate-to-severe MS disability.

Sponsors & Collaborators

  • The Ottawa Hospital

    collaborator OTHER

  • Consortium of Multiple Sclerosis Centers

    collaborator OTHER

  • Queen's University

    collaborator OTHER

  • University of Ottawa

    lead OTHER

Principal Investigators

  • Lara Pilutti, PhD · University of Ottawa

  • Mark Freedman, MD · The Ottawa Hospital/Ottawa Hospital Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-04
Primary Completion
2022-06-12
Completion
2022-10-04

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267185 on ClinicalTrials.gov